{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:16:46Z","timestamp":1788585406476,"version":"build-2803163510"},"reference-count":23,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2026,8,31]]},"DOI":"10.7883\/yoken.jjid.2026.047","type":"journal-article","created":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T22:10:17Z","timestamp":1788127817000},"source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the Virucidal Activity of Chlorine Dioxide against Hepatitis B Virus"],"prefix":"10.7883","author":[{"given":"Ming","family":"Chen","sequence":"first","affiliation":[{"name":"Taiko Pharmaceutical Co., Ltd., R&amp;D Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline Donzeli","family":"Pereira","sequence":"additional","affiliation":[{"name":"Taiko Pharmaceutical Co., Ltd., R&amp;D Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Watashi","sequence":"additional","affiliation":[{"name":"Department of Drug Development, National Institute of Infectious Diseases, Japan Institute for Health Security, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Shibata","sequence":"additional","affiliation":[{"name":"Taiko Pharmaceutical Co., Ltd., R&amp;D Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Miura","sequence":"additional","affiliation":[{"name":"Taiko Pharmaceutical Co., Ltd., R&amp;D Center, Japan"},{"name":"Department of Molecular Biochemistry and Clinical Investigation, Graduate School of Medicine, Osaka University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Lok ASF, Mcmahon BJ, Brown RS, et al. Antiviral therapy for chronic hepatitis B viral infection in adults: a systematic review and meta-analysis. Hepatology. 2016;63:284-306.","DOI":"10.1002\/hep.28280"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Sheena BS, Hiebert L, Han H, et al. Global, regional, and national burden of hepatitis B, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022;7:796-829.","DOI":"10.1016\/S2468-1253(22)00124-8"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Comstock RD, Mallonee S, Fox JL, et al. A large nosocomial outbreak of hepatitis C and hepatitis B among patients receiving pain remediation treatments. Infect Control Hosp Epidemiol. 2004;25:576-583.","DOI":"10.1086\/502442"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Lanini S, Puro V, Lauria FN, et al. Patient to patient transmission of hepatitis B virus: a systematic review of reports on outbreaks between 1992 and 2007. BMC Med. 2009;7:15.","DOI":"10.1186\/1741-7015-7-15"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Fabrizi F, Dixit V, Messa P, et al. Transmission of hepatitis B virus in dialysis units: a systematic review of reports on outbreaks. Int J Artif Organs. 2015;38:1-7.","DOI":"10.5301\/ijao.5000376"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Sattar SA, Tetro J, Springthorpe VS, et al. Preventing the spread of hepatitis B and C viruses: where are germicides relevant? Am J Infect Control. 2001;29:187-197.","DOI":"10.1067\/mic.2001.114233"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Than TT, Jo E, Todt D, et al. High environmental stability of hepatitis B virus and inactivation requirements for chemical biocides. J Infect Dis. 2019;219:1044-1048.","DOI":"10.1093\/infdis\/jiy620"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Payan C, Pivert A, Kampf G, et al. Assessment of new chemical disinfectants for HBV virucidal activity in a cell culture model. J Hosp Infect. 2004;56:58-63.","DOI":"10.1016\/j.jhin.2003.12.031"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Chung I, Ryu H, Yoon SY, et al. Health effects of sodium hypochlorite: review of published case reports. Environ Anal Health Toxicol. 2022;37:e2022006.","DOI":"10.5620\/eaht.2022006"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sanekata T, Fukuda T, Miura T, et al. Evaluation of the antiviral activity of chlorine dioxide and sodium hypochlorite against feline calicivirus, human influenza virus, measles virus, canine distemper virus, human herpesvirus, human adenovirus, canine adenovirus and canine parvovirus. Biocontrol Sci. 2010;15:45-49.","DOI":"10.4265\/bio.15.45"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hatanaka N, Xu B, Yasugi M, et al. Chlorine dioxide is a more potent antiviral agent against SARS-CoV-2 than sodium hypochlorite. J Hosp Infect. 2021;118:20-26.","DOI":"10.1016\/j.jhin.2021.09.006"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hinenoya A, Awasthi SP, Yasuda N, et al. Chlorine dioxide is a better disinfectant than sodium hypochlorite against multi-drug resistant Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii. Jpn J Infect Dis. 2015;68:276-279.","DOI":"10.7883\/yoken.JJID.2014.294"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Iwamoto M, Watashi K, Tsukuda S, et al. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP. Biochem Biophys Res Commun. 2014;443:808-813.","DOI":"10.1016\/j.bbrc.2013.12.052"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ogura N, Watashi K, Noguchi T, et al. Formation of covalently closed circular DNA in Hep38.7-Tet cells, a tetracycline inducible hepatitis B virus expression cell line. Biochem Biophys Res Commun. 2014;452:315-321.","DOI":"10.1016\/j.bbrc.2014.08.029"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Deng L, Gan X, Ito M, et al. Peroxiredoxin 1, a novel HBx-interacting protein, interacts with exosome component 5 and negatively regulates hepatitis B virus propagation through degradation of HBV RNA. J Virol. 2019;93:e02203-18.","DOI":"10.1128\/JVI.02203-18"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Xia Y, Cheng X, Blossey CK, et al. Secreted interferon-inducible factors restrict hepatitis B and C virus entry in vitro. J Immunol Res. 2017;2017:4828936.","DOI":"10.1155\/2017\/4828936"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Sauerbrei A. Is hepatitis B-virucidal validation of biocides possible with the use of surrogates? World J Gastroenterol. 2014;20:436-444.","DOI":"10.3748\/wjg.v20.i2.436"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Hu J, Liu K. Complete and incomplete hepatitis B virus particles: formation, function, and application. Viruses. 2017;9:56.","DOI":"10.3390\/v9030056"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Peredo-Lovillo A, Romero-Luna HE, Ju\u00e1rez-Trujillo N, et al. Antimicrobial efficiency of chlorine dioxide and its potential use as anti-SARS-CoV-2 agent: mechanisms of action and interactions with gut microbiota. J Appl Microbiol. 2023;134:lxad133.","DOI":"10.1093\/jambio\/lxad133"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ogata N. Denaturation of protein by chlorine dioxide: oxidative modification of tryptophan and tyrosine residues. Biochemistry. 2007;46:4898-4911.","DOI":"10.1021\/bi061827u"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ogata N. Inactivation of influenza virus haemagglutinin by chlorine dioxide: oxidation of the conserved tryptophan 153 residue in the receptor-binding site. J Gen Virol. 2012;93:2558-2563.","DOI":"10.1099\/vir.0.044263-0"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Tsukuda S, Watashi K. Hepatitis B virus biology and life cycle. Antiviral Res. 2020;182:104925.","DOI":"10.1016\/j.antiviral.2020.104925"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kunz S, Soppa L, Leidolf R, et al. Interaction between W41 of the hepatitis B virus preS1 surface peptide and Y146\/F274 of the cellular receptor molecule Na<sup>+<\/sup>\/taurocholate co-transporting polypeptide is essential for virus entry. Mol Pharmacol. 2025;107:100069.","DOI":"10.1016\/j.molpha.2025.100069"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/advpub\/0\/advpub_JJID.2026.047\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:45:28Z","timestamp":1788583528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/advpub\/0\/advpub_JJID.2026.047\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2026.047","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"article-number":"JJID.2026.047"}}